The role of APC and beta-catenin in the aetiology of aggressive fibromatosis (desmoid tumors)

European Journal of Surgical Oncology

Volumn 35, Issue 1, 2009, Pages 3-10

  Lips, D J ^a   Barker, N ^b   Clevers, H ^b   Hennipman, A ^c  

^a JEROEN BOSCH HOSPITAL   (Netherlands)

^b HUBRECHT INSTITUTE   (Netherlands)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

catenin; adenomatous polyposis coli; desmoid tumor; fibromatosis, aggressive

Indexed keywords

ANTINEOPLASTIC AGENT; APC PROTEIN; BETA CATENIN; WNT1 PROTEIN;

COLON POLYPOSIS; DESMOID TUMOR; DISEASE CLASSIFICATION; DISEASE COURSE; GENE MUTATION; HORMONAL THERAPY; HUMAN; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION;

ADENOMATOUS POLYPOSIS COLI PROTEIN; BETA CATENIN; FIBROMATOSIS, AGGRESSIVE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, APC; HUMANS; MUTATION; SIGNAL TRANSDUCTION;

EID: 57549089267     PISSN: 07487983     EISSN: 15322157     Source Type: Journal    
DOI: 10.1016/j.ejso.2008.07.003     Document Type: Review

References (66)

1. Pikaar A., Nortier J.W.R., Griffioen G., and Vasen H.F.A. Desmoid tumoren bij patienten met familiaire adenomateuze polyposis. NTvG 146 29 (2002) 1355-1359
2. Nuyttens J.J., Rust P.F., and Thomas Jr. C.R. Turrisi AT III. Surgery versus radiation therapy for patients with aggressive fibromatosis or desmoid tumor. Cancer 88 (2000) 1517-1523
3. Pignatti G., Barbanti-Brodano G., Ferrari D., et al. Extraabdominal desmoid tumor. Clin Orthop Res 375 (2000) 207-213
4. Godwin Y., McCulloch T.A., and Sully L. Extra-abdominal desmoid tumour of the breast: review of the primary management and the implications for breast reconstruction. Br J Plast Surg 54 3 (2001) 268-271
5. Eccles D.M., van der Luijt R., Breukel C., et al. Hereditary desmoid disease due to a frameshift mutation at codon 1924 of the APC gene. Am J Hum Genet 59 6 (1996) 1193-1201
6. Scott R.J., Froggatt N.J., Trembath R.C., Evans D.G., Hodgson S.V., and Maher E.R. Familial infiltrative fibromatosis (desmoid tumours) (MIM135290) caused by a recurrent 3′ APC gene mutation. Hum Mol Genet 5 12 (1996) 1921-1924
7. Bandipalliam P., Balmana J., and Syngal S. Comprehensive genetic and endoscopic evaluation may be necessary to distinguish sporadic versus familial adenomatous polyposis-associated abdominal desmoid tumors. Surgery 135 6 (2004) 683-689
8. Benoit L., Faivre L., Cheynel N., et al. 3′ Mutation of the APC gene and family history of FAP in a patient with apparently sporadic desmoid tumors. J Clin Gastroenterol 41 3 (2007) 297-300
9. Gronchi A., Casali P.G., Mariani L., et al. Quality of surgery and outcome in extra-abdominal aggressive fibromatosis: a series of patients surgically treated at a single institution. J Clin Oncol 21 7 (2006) 1390-1397
10. Merchant N.B., Lewis J.J., Woodruff J.M., Leung D.H.Y., and Brennan M.F. Extremity and trunk desmoid tumors: a multifactorial analysis of outcome. Cancer 86 (1999) 2045-2052
11. Lev D., Kotilingam D., Wei C., et al. Optimizing treatment of desmoid tumors. J Clin Oncol 25 13 (2007) 1785-1791
12. Heinrich M.C., McArthur G.A., Demetri G.D., et al. Clinical and molecular studies of the effect of imatinib on advanced aggressive fibromatosis (desmoid tumor). J Clin Oncol 24 7 (2006) 1195-1203
13. Azzarelli A., Gronchi A., Bertulli R., et al. Low-dose chemotherapy with methotrexate and vinblastine for patients with advanced aggressive fibromatosis. Cancer 92 5 (2001) 1259-1264
14. Nieuwenhuis M.H., De Vos Tot Nederveen C., Botma A., et al. Desmoid tumors in a dutch cohort of patients with familial adenomatous polyposis. Clin Gastroenterol Hepatol 6 2 (2008) 215-219
15. Ishizuka M., Hatori M., Dohi O., et al. Expression profiles of sex steroid receptors in desmoid tumors. Tohoku J Exp Med 210 3 (2006) 189-198
16. Deyrup A.T., Tretiakova M., and Montag A.G. Estrogen receptor-beta expression in extraabdominal fibromatoses: an analysis of 40 cases. Cancer 106 1 (2006) 208-213
17. Li M., Cordon-Cardo C., Gerald W.L., and Rosai J. Desmoid fibromatosis is a clonal process. Hum Pathol 27 9 (1996) 939-943
18. Bacac M., Migliavacca E., Stehle J.-C., et al. A gene expression signature that distinguishes desmoid tumours from nodular fasciitis. J Pathol 208 (2006) 543-553
19. Taconis W.K., and Schutte H.E. Van der Heul RO. Desmoplastic fibroma of bone: a report of 18 cases. Skelet Radiol 23 (1994) 283-288
20. Hoos A., Lewis J.J., Antonescu C.R., et al. Characterization of molecular abnormalities in human fibroblastic neoplasms: a model for genotype-phenotype association in soft tissue tumors. Cancer Res 61 April 1 (2001) 3171-2175
21. Fletcher J.A., Naeem R., Xiao S., and Corson J.M. Chromosome aberrations in desmoid tumors. Cancer Genet Cytogenet 79 139 (1995) 143
22. Kouho H., Aoki T., Hisaoka M., and Hashimoto H. Clinicopathological and interphase cytogenetic analysis of desmoid tumors. Histopathology 31 (1997) 336-341
23. Bridge J.A., Swarts S.J., Buresh C., et al. Trisomies 8 and 20 characterize a subgroup of benign fibrous lesions arising in both soft tissue and bone. Am J Pathol 154 (1999) 729-733
24. Kopp P., Jaggi R., Tobler A., et al. Clonal X-inactivation analysis of human tumours using the human androgen receptor gene (HUMARA) polymorphism: a non-radioactive and semiquantitative strategy applicable to fresh and archival tissue. Mol Cell Probes 11 3 (1997) 217-228
25. Muller E., Castagnaro M., Yandel D., Wolfe H., and Alman B.A. Molecular genetic and immunohistochemical analysis of the tumor suppressor genes Rb and P53 in palmar and aggressive fibromatosis. Diag Mol Pathol 5 3 (1996) 194-200
26. Smits R. Van der Houven van Oordt W, Luz A, et al. Apc1638N: a mouse model for familial adenomatous polyposis-associated desmoid tumors and cutaneous cysts. Gastroenterology 114 (1998) 275-283
27. Robbins D.H., and Itzkowitz S.H. The molecular and genetic basis of colon cancer. Med Clin North Am 86 6 (2002) 1467-1495
28. Brueckl W.M., Preuss J.M., Wein A., et al. Ki-67 expression and residual tumour (R) classification are associated with disease-free survival in desmoid tumour patients. Anticancer Res 21 5 (2001) 3615-3620
29. Gebert C., Hardes J., Kersting C., et al. Expression of beta-catenin and p53 are prognostic factors in deep aggressive fibromatosis. Histopathology 50 4 (2007) 491-497
30. Clark S.K., Neale K.F., Landgrebe J.C., and Phillips R.K. Desmoid tumours complicating familial adenomatous polyposis. Br J Surg 86 9 (1999) 1185-1189
31. Couture J., Mitri A., Lagace R., et al. A germline mutation at the extreme 3′ end of the APC gene results in a severe desmoid phenotype and is associated with overexpression of beta-catenin in the desmoid tumor. Clin Genet 57 (2000) 205-212
32. Gurbuz A.K., Giardiello F.M., and Petersen G.M. Desmoids tumours in familial adenomatous polyposis. Gut 35 (1994) 377-381
33. Latchford A.R., Sturt N.J.H., Neale K., Rogers P.A., and Phillips R. A 10-year review of surgery for desmoid disease associated with familial adenomatous polyposis. Br J Surg 93 (2006) 1258-1264
34. Speake D., Evans D.G., Lalloo F., Scott N.A., and Hill J. Desmoid tumours in patients with familial adenomatous polyposis and desmoid region adenomatous polyposis coli mutations. Br J Surg 94 8 (2007) 1009-1013
35. Smith K.J., Johnson K.A., Bryan T.M., et al. The APC gene product in normal and tumor cells. Proc Natl Acad Sci USA 90 7 (1993) 2846-2850
36. Lamlum H., Ilyas M., Rowan A., et al. The type of somatic mutation at APC in familial adenomatous polyposis is determined by the site of the germline mutation: a new facet to Knudson's 'two-hit' hypothesis. Nat Med 5 9 (1999) 1071-1075
37. Bertario L., Russo A., Sala P., et al. Genotype and phenotype factors as determinants of desmoid tumors in patients with familial adenomatous polyposis. Int J Cancer 95 (2001) 102-107
38. Gould K.A., Dietrich W.F., Borenstein N., Lander E.S., and Dove W.F. Mom1 is a semi-dominant modifier of intestinal adenoma size and multiplicity in Min/+ mice. Genetics 144 4 (1996) 1769-1776
39. Oshima M., Oshima H., Kitagawa K., Kobayashi M., Itakura C., and Taketo M.M. Loss of APC heterozygosity and abnormal tissue building in nascent intestinal polyps in mice carrying a truncated APC gene. Proc Natl Acad Sci USA 92 10 (1995) 4482-4486
40. Smits R., Kielman M.F., Breukel C., et al. Apc1638T: a Mouse model delineating critical domains of the adenomatous polyposis coli protein involved in tumorigenesis and development. Genes Dev 13 10 (1999) 1309-1321
41. Su L.K., Kinzler K.W., Vogelstein B., et al. Multiple intestinal neoplasia caused by a mutation in the murine homolog of the APC gene. Science 256 5057 (1992) 668-670
42. Ikeda S., Kishida S., Yamamoto H., Murai H., Koyama S., and KikuchiAxin A. a negative regulator of the wnt signaling pathway, forms a complex with GSK-3beta and beta-catenin and promotes GSK-3beta-dependent phosphorylation of beta-catenin. EMBO J 17 5 (1998) 1371-1384
43. Korinek V., Barker N., Morin P.J., et al. Constitutive transcriptional activation by a beta-catenin-tcf complex in APC-/- colon carcinoma. Science 275 (1997) 1784-1787
44. Morin P.J., Sparks A.B., Korinek V., et al. Activation of beta-catenin-tcf signaling in colon cancer by mutations in beta-catenin or APC. Science 275 5307 (1997) 1787-1790
45. He T.C., Sparks A.B., Rago C., et al. Identification of C-MYC as a target of the APC pathway. Science 281 5382 (1998) 1509-1512
46. van de Wetering M., Sancho E., Verweij C., et al. The beta-catenin/TCF-4 complex imposes a crypt progenitor phenotype on colorectal cancer cells. Cell 111 2 (2002) 241-250
47. Saito T., Oda Y., Kawaguchi K.-I., et al. Possible association between higher beta-catenin mRNA expression and mutated beta-catenin in sporadic desmoid tumors: real-time semiquantitative assay by TaqMan polymerase chain reaction. Lab Invest 82 1 (2002) 97-103
48. Trent J.M., Wiltshire R., Su L.K., et al. The gene for the APC-binding protein beta-catenin (CTNNB1) maps to chromosome 3p22, a region frequently altered in human malignancies. Cytogenet Cell Genet 71 4 (1995) 343-344
49. Miyaki M., Konishi M., Kikuchi-Yanoshita R., et al. Coexistence of somatic and germ-line mutations of APC gene in desmoid tumors from patients with familial adenomatous polyposis. Cancer Res 53 21 (1993) 5079-5082
50. Alman B.A., Li C., Pajerski M.E., Diaz-Cano S., and Wolfe H.J. Increased beta-catenin protein and somatic APC mutations in sporadic aggressive fibromatosis (desmoid tumor). Am J Pathol 151 (1997) 329-334
51. Miyoshi Y., Iwao K., Nawa G., Yoshikawa H., Ochi T., and Nakamura Y. Frequent mutations in the beta-catenin gene in desmoid tumors from patients without familial adenomatous polyposis. Oncol Res 10 11-12 (1998) 591-594
52. Tejpar S., Michils G., Denys H., et al. Analysis of Wnt/beta catenin signalling in desmoid tumors. Acta Gastroenterol Belg 68 1 (2005) 5-9
53. Brueckl W.M., Ballhausen W.G., Fortsch T., et al. Genetic testing for germline mutations of the APC gene in patients with apparently sporadic desmoid tumors but a family history of colorectal carcinoma. Dis Colon Rectum 48 6 (2005) 1275-1281
54. Giarola M., Wells D., Mondini P., et al. Mutations of adenomatous polyposis coli (APC) gene are uncommon in sporadic desmoid tumors. Br J Cancer 78 5 (1998) 582-587
55. Li C., Bapat B., and Alman B.A. Adenomatous polyposis coli gene mutation alters proliferation through its beta-catenin-regulatory function in aggressive fibromatosis (desmoid tumor). Am J Pathol 153 3 (1998) 709-714
56. Shitoh K., Konishi F., Iijima T., et al. A novel case of a sporadic desmoid tumour with mutation of the beta-catenin gene. J Clin Pathol 52 (1999) 695-696
57. Poon R., Smits R., Li C., et al. Cyclooxygenase-Two (COX-2) modulates proliferation in aggressive fibromatosis (desmoid tumor). Oncogene 20 4 (2001) 451-460
58. Tejpar S., Nollet F., Li C., et al. Predominance of beta-catenin mutations and beta-catenin dysregulation in sporadic aggressive fibromatosis (desmoid tumor). Oncogene 18 47 (1999) 6615-6620
59. Tajima S., Hironaka M., Oshikawa K., et al. Intrathoracic sporadic desmoid tumor with the beta-catenin gene mutation in exon 3 and activated cyclin D1. Respiration 73 4 (2006) 558-561
60. Cheon S.S., Cheah A.Y., Turley S., et al. Beta-catenin stabilization dysregulates mesenchymal cell proliferation, motility, and invasiveness and causes aggressive fibromatosis and hyperplastic cutaneous wounds. Proc Natl Acad Sci USA 99 10 (2002) 6973-6978
61. Dangel A., Meloni A., Lynch H.T., and Sandberg A.A. Deletion (5q) in a desmoid tumor of patient with Gardner's syndrome. Cancer Genet Cytogenet 78 1 (1994) 94-98
62. Sturt N.J.H., Gallagher M.C., Bassett P., et al. Evidence for genetic predisposition to desmoid tumours in familial adenomatous polyposis independent of the germline APC mutation. Gut 53 12 (2004) 1832-1836
63. van der Luijt R., Meera Khan P., Vasen H.F.A., et al. germline mutations in the 3′ part of APC Exon 15 do not result in truncated proteins and are associated with attenuated adenomatous polyposis coli. Hum Genet 98 6 (1996) 727-734
64. Halberg R.B., Katzung D.S., Hoff P.D., et al. Tumorigenesis in the multiple intestinal neoplasia mouse: redundancy of negative regulators and specificity of modifiers. Proc Natl Acad Sci USA 97 7 (2000) 3461-3466
65. Li C.F., MacDonald J.R., Wei R.Y., et al. Human sterile alpha motif domain 9, a novel gene identified as down-regulated in aggressive fibromatosis, is absent in the mouse. BMC Genomics 8 92 (2007)
66. Fong Y., Rosen P.P., and Brennan M.F. Multifocal desmoids. Surgery 114 (1993) 902-906